UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000007301
Receipt No. R000008609
Official scientific title of the study Effect of nasal corticosteroids on pathophysiology of bronchial asthma
Date of disclosure of the study information 2012/02/20
Last modified on 2016/10/02 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effect of nasal corticosteroids on pathophysiology of bronchial asthma
Title of the study (Brief title) Nasal corticosteroids and asthma
Region
Japan

Condition
Condition bronchial asthma
allergic rhinitis
Classification by specialty
Medicine in general Pneumology Clinical immunology
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effect of nasal corticosteroids on pathophysiology of asthma with allergic rhinitis
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Asthma control questionnaire
lung function test
exhaled nitric oxide
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Nasal corticosteroids
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria Asthma
Allergic rhinitis
Key exclusion criteria 1, Diagnosed with non-asthma respiratory disorders
2, Poor adherence
3, Use nasal corticosteroids within 8 weeks before enrollment
4, The patients who are inappropriate considered by physician
Target sample size 100

Research contact person
Name of lead principal investigator Kazuto Matsunaga
Organization Wakayama Medical University
Division name Third Department of Internal Medicine
Address 811-1 Kimiidera, Wakayama
TEL
Email

Public contact
Name of contact person Kazuto Matsunaga
Organization Wakayama Medical University
Division name Third Department of Internal Medicine
Address
TEL
Homepage URL
Email

Sponsor
Institute Third Department of Internal Medicine, Wakayama Medical University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 02 Month 20 Day

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 02 Month 15 Day
Anticipated trial start date
2012 Year 02 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 02 Month 15 Day
Last modified on
2016 Year 10 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008609